Abstract
Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes.
Original language | English |
---|---|
Pages (from-to) | 515-516 |
Number of pages | 2 |
Journal | Nature Reviews Endocrinology |
Volume | 8 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sep 2012 |
Externally published | Yes |